Tech Company Financing Transactions

Entra Pharmaceuticals Funding Round

On 1/6/2009, Entra Pharmaceuticals raised $4.2 million in Series A investment from private investors.

Transaction Overview

Announced On
1/6/2009
Transaction Type
Venture Equity
Amount
$4,200,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
950 Winter Street
Waltham, MA 02451
USA
Website
Email Address
Not Recorded
Overview
The company is developing various drug delivery technologies.
Profile
Entra Pharmaceuticals LinkedIn Company Profile
Social Media
Entra Pharmaceuticals Company Twitter Account
Company News
Entra Pharmaceuticals News
Facebook
Entra Pharmaceuticals on Facebook
YouTube
Entra Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frank Bobe
  Frank Bobe LinkedIn Profile  Frank Bobe Twitter Account  Frank Bobe News  Frank Bobe on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/6/2009: Anacor Pharmaceuticals venture capital transaction
Next: 1/6/2009: FTRANS venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary